Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
Chemical Research in Toxicology|April 18, 2012
Potential role of a quetiapine metabolite in quetiapine-induced neutropenia and agranulocytosisXiaohai Li, Michael D Cameron
Current Medicinal Chemistry|September 2, 2014
Gauging reactive metabolites in drug-induced toxicityMarsha R Eno, Michael D Cameron
Expert Opinion on Drug Metabolism & Toxicology|August 6, 2010
Metabolism considerations for kinase inhibitors in cancer treatmentDerek R Duckett, Michael D Cameron
Chemical Research in Toxicology|October 7, 2009
Bioactivation of the epidermal growth factor receptor inhibitor gefitinib: implications for pulmonary and hepatic toxicitiesXiaohai Li, Theodore M Kamenecka, Michael D Cameron
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 13, 2010
Cytochrome P450-mediated bioactivation of the epidermal growth factor receptor inhibitor erlotinib to a reactive electrophileXiaohai Li, Theodore M Kamenecka, Michael D Cameron
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 15, 2012
Discovery of a highly selective CYP3A4 inhibitor suitable for reaction phenotyping studies and differentiation of CYP3A4 and CYP3A5Xiaohai Li, Xinyi Song, Theodore M Kamenecka, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 25, 2007
In vitro prediction and in vivo verification of enantioselective human tofisopam metabolite profilesMichael D Cameron, Jason Wright, Christopher B Black, et al.
Chemical Research in Toxicology|March 10, 2016
P450 3A-Catalyzed O-Dealkylation of Lapatinib Induces Mitochondrial Stress and Activates Nrf2Marsha Rebecca Eno, Bahaa El-Dien M El-Gendy, Michael D Cameron
Pageof 15